LSHTM launches new centre of innovation to tackle antimicrobial resistance and tuberculosis

  10 July 2021

The London School of Hygiene & Tropical Medicine’s (LSHTM) research into tackling antimicrobial resistance and tuberculosis has been boosted through a new partnership with Johnson & Johnson.

LSHTM will host the inaugural J&J Center for Global Health Discovery (J&J CGHD). It marks the start of a new network of unique research partnerships between Johnson & Johnson and leading academic institutions to accelerate research into major global health challenges.

The J&J CGHD will advance the critical, early-stage discovery and exploratory science needed to develop potentially lifesaving innovations to address diseases that disproportionately impact the world’s poorest and most vulnerable people.

Further reading: LSHTM
Author(s): LSHTM
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed